CTT Pharmaceutical Holdings (CTTH) Stock Overview

Engages in the development of oral drug delivery systems for pain management and treatment. More details

CTTH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue ($0)

Does not have a meaningful market cap ($4M)

Highly volatile share price over the past 3 months compared to the US market

Has less than 1 year of cash runway

CTTH Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW497,212 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

497,212 investors already sharing narratives

View all narratives

CTT Pharmaceutical Holdings, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for CTT Pharmaceutical Holdings
Historical stock prices
Current Share Price	US$0.075
52 Week High	US$0.10
52 Week Low	US$0.02
Beta	0.72
1 Month Change	-3.72%
3 Month Change	15.38%
1 Year Change	150.00%
3 Year Change	426.32%
5 Year Change	49.25%
Change since IPO	-82.14%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	CTTH	US Pharmaceuticals	US Market
7D	0%	1.4%	1.6%
1Y	150.0%	48.6%	18.6%

Return vs Industry: CTTH exceeded the US Pharmaceuticals industry which returned 48.6% over the past year.

Return vs Market: CTTH exceeded the US Market which returned 18.6% over the past year.

Price Volatility

Is CTTH's price volatile compared to industry and market?
CTTH volatility
CTTH Average Weekly Movement	17.2%
Pharmaceuticals Industry Average Movement	9.5%
Market Average Movement	7.3%
10% most volatile stocks in US Market	16.7%
10% least volatile stocks in US Market	3.2%

Stable Share Price: CTTH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: CTTH's weekly volatility has decreased from 26% to 17% over the past year, but is still higher than 75% of US stocks.

About the Company

Founded	Employees	CEO	Website
n/a	1	Ryan Khouri	www.cttpharmaceuticals.com

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.

CTT Pharmaceutical Holdings, Inc. Fundamentals Summary

How do CTT Pharmaceutical Holdings's earnings and revenue compare to its market cap?
CTTH fundamental statistics
Market cap	US$4.40m
Earnings (TTM)	-US$211.04k
Revenue (TTM)	n/a

0.0x

P/S Ratio

-20.9x

P/E Ratio

Is CTTH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CTTH income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$211.04k
Earnings	-US$211.04k

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0036
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	45.6%

How did CTTH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/06 15:05
End of Day Share Price	2026/07/02 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CTT Pharmaceutical Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.